| 0 (0%) | 12-05 09:28 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.98  |
1-year : | 1.44 |
| Resists | First : | 0.84 |
Second : | 1.24 |
| Pivot price | 0.25 |
|||
| Supports | First : | 0.2 | Second : | 0.16 |
| MAs | MA(5) : | 0.23 |
MA(20) : | 0.4 |
| MA(100) : | 0.64 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2  |
Signal : | -0.2 |
| %K %D | K(14,3) : | 2.5 |
D(3) : | 2.1 |
| RSI | RSI(14): 29.1 |
|||
| 52-week | High : | 1.5 | Low : | 0.2 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ APLT ] has closed above bottom band by 26.6%. Bollinger Bands are 78.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.24 - 0.24 | 0.24 - 0.24 |
| Low: | 0.21 - 0.21 | 0.21 - 0.21 |
| Close: | 0.23 - 0.23 | 0.23 - 0.23 |
Wed, 03 Dec 2025
Leerink Partners Downgrades Applied Therapeutics(APLT.US) to Hold Rating, Cuts Target Price to $1 - 富途牛牛
Wed, 03 Dec 2025
APLT Downgraded by Leerink Partners: Key Analyst Update | APLT S - GuruFocus
Wed, 03 Dec 2025
New Analyst Forecast: $APLT Given $1 Price Target - Quiver Quantitative
Sat, 29 Nov 2025
Investment Review: Why APLT stock could benefit from AI revolution - July 2025 Macro Moves & Safe Entry Trade Reports - BỘ NỘI VỤ
Thu, 27 Nov 2025
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - Yahoo Finance
Fri, 14 Nov 2025
Are Applied Therapeutics' (APLT) Narrowing Losses a Turning Point for Its Strategic Vision? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 144 (M) |
| Held by Insiders | 1.1842e+008 (%) |
| Held by Institutions | 5.6 (%) |
| Shares Short | 8,980 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -9.961e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 796.7 % |
| Return on Equity (ttm) | -88.4 % |
| Qtrly Rev. Growth | 1e+006 % |
| Gross Profit (p.s.) | 372.9 |
| Sales Per Share | -352.58 |
| EBITDA (p.s.) | -1.97202e+007 |
| Qtrly Earnings Growth | -0.2 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -87 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 1.215e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|